Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 241 | PMVP | PMV PHARMACEUTICALS INC | Healthcare | 231,008.0 | $286K | 0.02% | NEW | — | $1.24 | +4.0% |
| 242 | TRAW | TRAWS PHARMA INC | Healthcare | 154,098.0 | $282K | 0.02% | NEW | — | $1.83 | -18.3% |
| 243 | JBIO | JADE BIOSCIENCES INC | Healthcare | 20,000.0 | $281K | 0.02% | NEW | — | $14.05 | +63.3% |
| 244 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 13,400.0 | $281K | 0.02% | NEW | — | $20.95 | +11.8% |
| 245 | — | PROCAP ACQUISITION CORP | — | 26,940.0 | $279K | 0.02% | NEW | — | $10.34 | — |
| 246 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 13,705.0 | $273K | 0.02% | NEW | — | $19.89 | +3.2% |
| 247 | RXST | RXSIGHT INC | Healthcare | 43,250.0 | $266K | 0.02% | NEW | — | $6.16 | +0.0% |
| 248 | PANW | PALO ALTO NETWORKS INC | Technology | 1,600.0 | $257K | 0.01% | NEW | — | $160.32 | +56.1% |
| 249 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 19,517.0 | $250K | 0.01% | NEW | — | $12.82 | -6.1% |
| 250 | CRWD | CROWDSTRIKE HLDGS INC | Technology | 640.0 | $250K | 0.01% | NEW | — | $390.41 | +68.3% |
| 251 | RBRK | RUBRIK INC. | Technology | 4,900.0 | $240K | 0.01% | NEW | — | $48.97 | +34.9% |
| 252 | RPRX | ROYALTY PHARMA PLC | Healthcare | 5,000.0 | $240K | 0.01% | NEW | — | $47.97 | +10.1% |
| 253 | SGRY | SURGERY PARTNERS INC | Healthcare | 20,000.0 | $238K | 0.01% | NEW | — | $11.92 | +11.2% |
| 254 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 52,745.0 | $237K | 0.01% | NEW | — | $4.50 | -22.0% |
| 255 | EOLS | EVOLUS INC | Healthcare | 55,859.0 | $230K | 0.01% | NEW | — | $4.11 | +59.4% |
| 256 | QTTB | Q32 BIO INC | Healthcare | 35,000.0 | $225K | 0.01% | NEW | — | $6.42 | -11.2% |
| 257 | — | LONGEVERON INC | — | 200,000.0 | $208K | 0.01% | NEW | — | $1.04 | — |
| 258 | ANAB | ANAPTYSBIO INC | Healthcare | 3,698.0 | $205K | 0.01% | NEW | — | $55.46 | +9.4% |
| 259 | CEPS | CANTOR EQUITY PARTNERS VI IN | Financial Services | 20,000.0 | $202K | 0.01% | NEW | — | $10.10 | +0.7% |
| 260 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 10,000.0 | $201K | 0.01% | NEW | — | $20.13 | +33.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%